ExodusPoint Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-91,303
| Closed | -$3.11M | – | 1470 |
|
|
2025
Q1 | $3.11M | Buy |
91,303
+43,463
| +91% | +$1.48M | 0.03% | 508 |
|
|
2024
Q4 | $1.88M | Buy |
+47,840
| New | +$1.88M | 0.01% | 673 |
|
|
2024
Q2 | – | Sell |
-16,682
| Closed | -$1.14M | – | 1462 |
|
|
2024
Q1 | $1.14M | Buy |
+16,682
| New | +$1.14M | 0.01% | 797 |
|
|
2023
Q4 | – | Sell |
-34,331
| Closed | -$1.56M | – | 1482 |
|
|
2023
Q3 | $1.56M | Sell |
34,331
-2,232
| -6% | -$101K | 0.01% | 733 |
|
|
2023
Q2 | $2.05M | Sell |
36,563
-16,257
| -31% | -$913K | 0.02% | 713 |
|
|
2023
Q1 | $2.39M | Buy |
52,820
+27,379
| +108% | +$1.24M | 0.02% | 718 |
|
|
2022
Q4 | $1.03M | Buy |
25,441
+8,221
| +48% | +$334K | 0.02% | 903 |
|
|
2022
Q3 | $1.13M | Buy |
+17,220
| New | +$1.13M | 0.01% | 1030 |
|
|
2022
Q1 | – | Sell |
-15,522
| Closed | -$1.18M | – | 2203 |
|
|
2021
Q4 | $1.18M | Buy |
15,522
+6,276
| +68% | +$475K | 0.01% | 951 |
|
|
2021
Q3 | $1.04M | Buy |
+9,246
| New | +$1.04M | 0.01% | 965 |
|
|
2021
Q2 | – | Sell |
-2,514
| Closed | -$306K | – | 2345 |
|
|
2021
Q1 | $306K | Sell |
2,514
-3,328
| -57% | -$405K | ﹤0.01% | 1609 |
|
|
2020
Q4 | $894K | Buy |
+5,842
| New | +$894K | 0.01% | 852 |
|
|
2020
Q2 | – | Sell |
-6,242
| Closed | -$265K | – | 1778 |
|
|
2020
Q1 | $265K | Buy |
+6,242
| New | +$265K | 0.01% | 653 |
|